MedChemComm · 2011 · 24 citations · 4 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationChemical Library DesignChemical Space ExplorationHit-to-lead OptimizationMolecular DockingMolecular Targets Of DrugsPotency OptimizationKinase Inhibitor Library DesignMedicinal Chemistry ApplicationsPyrimidine AnalogsPyrimidine AnaloguesPyrimidine ChemistrySar Interpretation
A high throughput chemical screening campaign has led to the identification of 3-aminobenzo[b]thiophene-2-carboxamides as LIMK1 inhibitors. Evolution of bicyclic hits to the tricyclic 4-aminobenzothieno[3,2-d]pyrimidine, using a traditional medicinal chemistry SAR guided approach, resulted in a significant increase in potency. Further elaboration has seen the 7-phenyl-4-aminobenzothieno[3,2-d]pyrimidine emerge as a LIMK1 inhibitor lead candidate.
4
A role for LIM kinase in cancer invasion
Kiyoko Yoshioka, Victoria C. Foletta, Ora Bernard et al. · Proceedings of the National Academy of Sciences · 2003 · 212 citations · Full text
De Novo Synthesis of a Potent LIMK1 Inhibitor
Brad E. Sleebs, Ian P. Street, Xian Zhang Bu et al. · Synthesis · 2010 · 12 citations